Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC01555 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF395 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RASGRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCG11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C12orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIEZO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC338667 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OOSP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPXM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on